Cardiovascular Disease Risk in Children With Chronic Kidney Disease: Impact of Apolipoprotein C-II and Apolipoprotein C-III
Cardiovascular disease (CVD) is an evolving process that begins in the early stages of chronic kidney disease (CKD) in children. Several surrogate markers, such as ambulatory blood pressure monitoring (ABPM), left ventricular (LV) mass, and arterial stiffness assessment, allow for the early detectio...
Saved in:
Main Authors: | Wei-Ling Chen (Author), You-Lin Tain (Author), Hung-En Chen (Author), Chien-Ning Hsu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiovascular Risks of Hypertension: Lessons from Children with Chronic Kidney Disease
by: You-Lin Tain, et al.
Published: (2022) -
Apolipoprotein C-II Deficiency with Encephalopathy
by: J Gordon Millichap
Published: (2003) -
Role of the Gut Microbiota in Children with Kidney Disease
by: You-Lin Tain, et al.
Published: (2023) -
Developmental Origins of Kidney Disease: Why Oxidative Stress Matters?
by: Chien-Ning Hsu, et al.
Published: (2020) -
Adherence to long-term use of renin-angiotensin II-aldosterone system inhibitors in children with chronic kidney disease
by: Chien-Ning Hsu, et al.
Published: (2019)